Corcept Therapeutics   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Menlo Park CA United States (1998)
Status: No NME R&D (1998)

Organization Overview

First Clinical Trial
2003
NCT00105105
First Marketed Drug
2012
mifepristone (mifeprex)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

CORCEPT THERAP | Corcept Therapeutics | Corcept Therapeutics, Menlo Park, CA 94025